Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
START Midwest, Grand Rapids, Michigan NEXT - Dallas, Dallas, Texas START - San Antonio, San Antonio, Texas NEXT - Virginia, Fairfax, Virginia